News Release 2009
Dec.24.2009
- Received top-grade grant from JST
Subject：“The development of RNA interference-based therapeutics for Crohn's disease stricture.”
JST; Japan Science and Technology Agency
Aug.27.2009
- Charles River Laboratories Japan, Inc. agrees to produce and sell Stelic’s NASH-HCC Mouse Model.
Aug.27.2009
- Received grant from NEDO : “Grant for Application of Industrial Technology Innovation”.
Jul.2.2009
- Stelic won cum laude recognition for a poster presentation in the 17th Japan Digestive Disease Week 2009(JDDW 2009). - Kyoto: Thursday, October 15, 2009
Subject：“Establishment of a novel NASH model mice establishment of a novel
NASH model mice representative human pathological condition”
Apr.1.2009
- Stelic announced the launch of contracting services for hepatic cancer (HCC) therapeutic evaluation, using Stelic’s novel NASH-HCC Mouse Model.
Feb.8.2009
- Stelic scientists participated in the second general meeting of Health and Labor Sciences Research Grants (HLSRG), on the “Research on intractable diseases” project.
